Patents Assigned to Genecast Biotechnology Co., Ltd.
  • METHODS AND PRODUCTS FOR MINIMAL RESIDUAL DISEASE DETECTION
    Publication number: 20220399080
    Abstract: Methods are disclosed for determining the minimal residual cancer status of an individual utilizing assays that detect cancer associated genetic variation in extracellular DNA. The disclosed methods provide for personalized cancer detection based on the genetic profile of solid cancer tissue of an individual under study. The disclosed methods further provide for noise reduction in the sequencing of extracellular DNA and reduced false positive rates in minimal residual cancer status determination.
    Type: Application
    Filed: September 30, 2021
    Publication date: December 15, 2022
    Applicants: Genecast (Beijing) Biotechnology Co., Ltd., Genecast (Taizhou) Biotechnology Co., Ltd., Genecast Biotechnology Co., Ltd.
    Inventors: Yaxi ZHANG, Hongyu XIE, Weizhi CHEN, Ying YANG, Rui FAN, Xiuyu ZHAO, Piao YANG, Jianing YU, Bo DU
  • METHODS AND PRODUCTS FOR MINIMAL RESIDUAL DISEASE DETECTION
    Publication number: 20220396837
    Abstract: Methods are disclosed for determining the minimal residual cancer status of an individual utilizing assays that detect cancer associated genetic variation in extracellular DNA. The disclosed methods provide for personalized cancer detection based on the genetic profile of solid cancer tissue of an individual under study. The disclosed methods further provide for noise reduction in the sequencing of extracellular DNA and reduced false positive rates in minimal residual cancer status determination.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 15, 2022
    Applicants: Genecast (Beijing) Biotechnology Co., Ltd., Zhenyue Biotechnology Jiangsu Co., Ltd., Genecast Biotechnology Co., Ltd.
    Inventors: Yaxi ZHANG, Hongyu XIE, Weizhi CHEN, Ying YANG, Rui FAN, Xiuyu ZHAO, Piao YANG, Jianing YU, Bo DU
  • DNA METHYLATION SEQUENCING ANALYSIS METHODS
    Publication number: 20220228209
    Abstract: Embodiments of the invention provides methods for determining a methylation score of DNA and determining a ctDNA Fraction (CTDF) value. Additional embodiments are as described herein.
    Type: Application
    Filed: September 30, 2021
    Publication date: July 21, 2022
    Applicants: Genecast Biotechnology Co., Ltd., Genecast (Beijing) Biotechnology Co., Ltd., Genecast (Wuxi) Precision Medicine Diagnostic Laboratory Co., Ltd.
    Inventors: Tiancheng Han, Xiaofeng Song, Jianing Yu, Yuanyuan Hong, Weizhi Chen, Bo Du